PriceTargets.com logo

Rite Aid - RAD Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $2.75
  • Forecasted Upside: 50.27%
  • Number of Analysts: 2
  • Breakdown:
  • 2 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.83 As of 06/2/2023 05:32 PM ET
▲ +0.07 (3.98%)

This chart shows the closing price for RAD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Rite Aid Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RAD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RAD

Analyst Price Target is $2.75
▲ +50.27% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Rite Aid in the last 3 months. The average price target is $2.75, with a high forecast of $4.50 and a low forecast of $1.00. The average price target represents a 50.27% upside from the last price of $1.83.

This chart shows the closing price for RAD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 2 investment analysts is to sell stock in Rite Aid. This Sell consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
Ratings as of
12/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
Ratings as of
3/9/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 3 sell ratings
Ratings as of
6/7/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings
Ratings as of
9/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings
Ratings as of
12/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings
Ratings as of
3/4/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings
Ratings as of
5/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings
Ratings as of
6/2/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/27/2023Deutsche Bank AktiengesellschaftLower Target$3.00 ➝ $1.00Low
10/3/2022Deutsche Bank AktiengesellschaftLower TargetSell$4.00 ➝ $3.00Low
9/30/2022Evercore ISILower TargetUnderperform$7.00 ➝ $4.50Low
8/26/2022Evercore ISIReiterated RatingSell$7.00Low
6/3/2022Deutsche Bank AktiengesellschaftBoost Target$2.00 ➝ $4.00High
4/18/2022Deutsche Bank AktiengesellschaftBoost Target$1.00 ➝ $2.00Low
4/7/2022Deutsche Bank AktiengesellschaftDowngradeHold ➝ SellHigh
10/20/2021Deutsche Bank AktiengesellschaftBoost TargetHold$13.00 ➝ $15.00High
9/24/2021Evercore ISIInitiated CoverageSell$11.00Medium
6/25/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$21.00 ➝ $12.00High
6/22/2021Deutsche Bank AktiengesellschaftLower TargetHold$27.00 ➝ $18.00High
6/9/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
3/25/2021Deutsche Bank AktiengesellschaftBoost TargetHold$17.00 ➝ $27.00High
12/18/2020Deutsche Bank AktiengesellschaftBoost TargetHold$9.00 ➝ $17.00High
9/25/2020Deutsche Bank AktiengesellschaftLower TargetHold$18.00 ➝ $9.00High
9/24/2020Evercore ISIBoost TargetUnderperform$4.00 ➝ $6.00High
6/26/2020JPMorgan Chase & Co.Boost TargetNeutral$12.00 ➝ $17.00High
6/26/2020Deutsche Bank AktiengesellschaftBoost TargetHold$12.00 ➝ $18.00High
4/17/2020Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold$12.00Low
2/27/2020GuggenheimUpgradeSell ➝ NeutralHigh
12/23/2019Deutsche Bank AktiengesellschaftBoost TargetSell$5.00 ➝ $12.00High
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageSell$5.00High
8/12/2019Evercore ISIReiterated RatingSellHigh
4/18/2019GuggenheimReiterated RatingSell ➝ SellHigh
12/20/2018Loop CapitalLower TargetHold$27.00 ➝ $20.00High
9/28/2018Loop CapitalSet TargetHold$20.00Low
9/24/2018Royal Bank of CanadaSet TargetHold$20.00Low
9/6/2018The Goldman Sachs GroupInitiated CoverageSell ➝ Sell$20.00High
8/13/2018CowenDowngradeOutperform ➝ Market Perform$47.00 ➝ $120.00High
8/9/2018MizuhoReiterated RatingHold$40.00Low
6/28/2018CowenReiterated RatingBuy$47.00High
(Data available from 6/2/2018 forward)

News Sentiment Rating

0.31 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 20 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
11/4/2022
  • 9 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2022
  • 5 very positive mentions
  • 22 positive mentions
  • 6 negative mentions
  • 2 very negative mentions
Mentions as of
1/3/2023
  • 3 very positive mentions
  • 12 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
Mentions as of
2/2/2023
  • 5 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/4/2023
  • 8 very positive mentions
  • 10 positive mentions
  • 6 negative mentions
  • 7 very negative mentions
Mentions as of
4/3/2023
  • 1 very positive mentions
  • 14 positive mentions
  • 7 negative mentions
  • 2 very negative mentions
Mentions as of
5/3/2023
  • 2 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2023

Current Sentiment

  • 2 very positive mentions
  • 13 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Rite Aid logo
Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.
Read More

Today's Range

Now: $1.83
Low: $1.79
High: $1.84

50 Day Range

MA: $2.11
Low: $1.76
High: $2.63

52 Week Range

Now: $1.83
Low: $1.67
High: $11.61

Volume

1,265,270 shs

Average Volume

2,400,719 shs

Market Capitalization

$103.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Rite Aid?

The following equities research analysts have issued reports on Rite Aid in the last twelve months: Deutsche Bank Aktiengesellschaft, Evercore ISI, and StockNews.com.
View the latest analyst ratings for RAD.

What is the current price target for Rite Aid?

2 Wall Street analysts have set twelve-month price targets for Rite Aid in the last year. Their average twelve-month price target is $2.75, suggesting a possible upside of 50.3%. Evercore ISI has the highest price target set, predicting RAD will reach $4.50 in the next twelve months. Deutsche Bank Aktiengesellschaft has the lowest price target set, forecasting a price of $1.00 for Rite Aid in the next year.
View the latest price targets for RAD.

What is the current consensus analyst rating for Rite Aid?

Rite Aid currently has 2 sell ratings from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe RAD will underperform the market and that investors should sell shares of Rite Aid.
View the latest ratings for RAD.

What other companies compete with Rite Aid?

Other companies that are similar to Rite Aid include PetMed Express, Conn's, Lulu's Fashion Lounge, Bed Bath & Beyond and FAT Brands. Learn More about companies similar to Rite Aid.

How do I contact Rite Aid's investor relations team?

Rite Aid's physical mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company's listed phone number is (717) 761-2633 and its investor relations email address is [email protected]. The official website for Rite Aid is www.riteaid.com. Learn More about contacing Rite Aid investor relations.